Firebrick Pharma (ASX:FRE) FCF Yield % : -11.68 (As of Apr. 09, 2025)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Firebrick Pharma's Trailing 12-Month Free Cash Flow is A$-1.99 Mil, and Market Cap is A$17.07 Mil. Therefore, Firebrick Pharma's FCF Yield % for today is -11.68%.

The historical rank and industry rank for Firebrick Pharma's FCF Yield % or its related term are showing as below:

ASX:FRE' s FCF Yield % Range Over the Past 10 Years
Min: -11.68 Med: 0 Max: 0
Current: -11.68

ASX:FRE's FCF Yield % is ranked worse than
78.03% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.12 vs ASX:FRE: -11.68

Firebrick Pharma's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Firebrick Pharma FCF Yield % Historical Data

The historical data trend for Firebrick Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma FCF Yield % Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

FCF Yield %

-9.47

-21.18

-21.44

Firebrick Pharma Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Yield %	Get a 7-Day Free Trial			-11.29	-26.28	-22.78	-24.34	-10.18

Competitive Comparison of Firebrick Pharma's FCF Yield %

For the Drug Manufacturers - General subindustry, Firebrick Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Firebrick Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Firebrick Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Firebrick Pharma's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.345	/	10.937192
	=	-21.44%

Firebrick Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.663	*	2	/	13.026758
	=	-10.18%

Firebrick Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Firebrick Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines